The effect of interferon beta-1b on lymphocyte-endothelial cell adhesion.

Abstract

Interferon beta-1b (IFN beta-1b) (Betaseron) has been recently approved for treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system (CNS). The mechanism of action of IFN beta-1b is not understood, but its effect in reducing gadolinium enhanced MRI lesions suggest an effect at the blood brain barrier (BBB… (More)

Topics

Cite this paper

@article{DhibJalbut1996TheEO, title={The effect of interferon beta-1b on lymphocyte-endothelial cell adhesion.}, author={Suhayl Dhib-Jalbut and Hao Jiang and G. J. Williams}, journal={Journal of neuroimmunology}, year={1996}, volume={71 1-2}, pages={215-22} }